(Q55412646)

7 July 2018

4 references

13 March 2019

24 March 2019

29 May 2020

27 November 2020

0 references

Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis. (English)

1 reference

7 July 2018

chronic renal insufficiency

3 references

13 March 2019

24 March 2019

29 May 2020

3 references

13 March 2019

24 March 2019

29 May 2020

1 reference

27 November 2020

Xuemei Liu

1

1 reference

7 July 2018

Tingting Zhai

2

1 reference

7 July 2018

Ruixia Ma

3

1 reference

7 July 2018

Congjuan Luo

4

1 reference

7 July 2018

Huifang Wang

5

1 reference

7 July 2018

Liqiu Liu

6

1 reference

7 July 2018

language of work or name

1 reference

1 November 2018

5 references

7 July 2018

13 March 2019

24 March 2019

29 May 2020

27 November 2020

5 references

7 July 2018

13 March 2019

24 March 2019

29 May 2020

27 November 2020

40

1 reference

7 July 2018

page(s)

289-297

1 reference

7 July 2018

issue

1

1 reference

7 July 2018

Creative Commons Attribution 4.0 International

copyright license

4 references

13 March 2019

24 March 2019

29 May 2020

on focus list of Wikimedia project

27 November 2020

ScienceSource

0 references

cites work

Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Efficacy and tolerability of febuxostat in hyperuricemic patients with or without gout: a systematic review and meta-analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Clinical outcome of hyperuricemia in IgA nephropathy: a retrospective cohort study and randomized controlled trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Uric acid and long-term outcomes in CKD

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Hypertension and renal disease: role of microalbuminuria

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Diabetic nephropathy as a cause of end-stage renal disease in Tabuk area, Saudi Arabia: a four-year study.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Risk of end-stage renal disease and death after cardiovascular events in chronic kidney disease

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

The role of uric acid in kidney fibrosis: experimental evidences for the causal relationship.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Serum uric acid and chronic kidney disease: the role of hypertension

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Adenine-induced chronic kidney and cardiovascular damage in rats.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

High burden and unmet patient needs in chronic kidney disease

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Effect of allopurinol in chronic kidney disease progression and cardiovascular risk

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

The effect of salicylates and adrenocorticotropic hormone upon the miscible pool of uric acid in gout

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Mild hyperuricemia induces glomerular hypertension in normal rats

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Studies of uric acid pool size and turnover rate

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6014338

Variance imputation for overviews of clinical trials with continuous response

12 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29619870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29619870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prevalence of chronic kidney disease in China: a cross-sectional survey

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29619870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1080/0886022X.2018.1456463

1 reference

7 July 2018

PMCID

6014338

1 reference

7 July 2018

PubMed ID

29619870

1 reference

7 July 2018